Clinical and molecular findings of the six patients with Rubinstein
Por um escritor misterioso
Descrição
Structural insights into the mechanism of leptin receptor activation
Rubinstein–Taybi syndrome European Journal of Human Genetics
CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder
High frequency of copy number imbalances in Rubinstein–Taybi patients negative to CREBBP mutational analysis
Innovative gene therapy may help treat a seve
Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation
Late phase 1 studies: concepts and outcomes - The Lancet Oncology
Cancers, Free Full-Text
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial - The Lancet
The proteogenomic subtypes of acute myeloid leukemia - ScienceDirect
Clinical photos of the patients. (a) Case 1: Dysmorphic facial features
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile Infection
Molecular biology of Hodgkin lymphoma